Witzel I - Search Results

1

Insights into the Steps of Breast Cancer-Brain Metastases Development: Tumor Cell Interactions with the Blood-Brain Barrier.

Hamester F, Stürken C, Saygi C, Qi M, Legler K, Gorzelanny C, Robador JR, Schmalfeldt B, Laakmann E, Müller V, Witzel I, Oliveira-Ferrer L. Hamester F, et al. Among authors: witzel i. Int J Mol Sci. 2022 Feb 8;23(3):1900. doi: 10.3390/ijms23031900. Int J Mol Sci. 2022. PMID: 35163822 Free PMC article.

2

Paradigmatic Approach to Support Personalized Counseling With Digital Health (iKNOW).

Speiser D, Heibges M, Besch L, Hilger C, Keinert M, Klein K, Rauwolf G, Schmid C, Schulz-Niethammer S, Stegen S, Westfal V, Witzel I, Zang B, Kendel F, Feufel MA. Speiser D, et al. Among authors: witzel i. JMIR Form Res. 2023 Apr 21;7:e41179. doi: 10.2196/41179. JMIR Form Res. 2023. PMID: 37083496 Free PMC article.

3

Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.

Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group. Turner NC, et al. N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131. N Engl J Med. 2023. PMID: 37256976 Clinical Trial.

4

Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.

Müller V, Witzel I, Lück HJ, Köhler G, von Minckwitz G, Möbus V, Sattler D, Wilczak W, Löning T, Jänicke F, Pantel K, Thomssen C. Müller V, et al. Among authors: witzel i. Breast Cancer Res Treat. 2004 Jul;86(1):9-18. doi: 10.1023/B:BREA.0000032919.83803.48. Breast Cancer Res Treat. 2004. PMID: 15218357 Clinical Trial.

5

Prognostic and predictive impact of soluble epidermal growth factor receptor (sEGFR) protein in the serum of patients treated with chemotherapy for metastatic breast cancer.

Müller V, Witzel I, Pantel K, Krenkel S, Lück HJ, Neumann R, Keller T, Dittmer J, Jänicke F, Thomssen C. Müller V, et al. Among authors: witzel i. Anticancer Res. 2006 Mar-Apr;26(2B):1479-87. Anticancer Res. 2006. PMID: 16619561 Free article. Clinical Trial.

6

Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancer.

Witzel I, Thomssen C, Krenkel S, Wilczak W, Bubenheim M, Pantel K, Neumann R, Jänicke F, Müller V. Witzel I, et al. Int J Biol Markers. 2006 Jul-Sep;21(3):131-40. doi: 10.1177/172460080602100301. Int J Biol Markers. 2006. PMID: 17013794 Free article.

7

Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.

Ihnen M, Müller V, Wirtz RM, Schröder C, Krenkel S, Witzel I, Lisboa BW, Jänicke F, Milde-Langosch K. Ihnen M, et al. Among authors: witzel i. Breast Cancer Res Treat. 2008 Dec;112(3):419-27. doi: 10.1007/s10549-007-9879-y. Epub 2008 Jan 3. Breast Cancer Res Treat. 2008. PMID: 18172759

8

Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.

Witzel ID, Milde-Langosch K, Wirtz RM, Roth C, Ihnen M, Mahner S, Zu Eulenburg C, Jänicke F, Müller V. Witzel ID, et al. J Cancer Res Clin Oncol. 2010 Nov;136(11):1709-18. doi: 10.1007/s00432-010-0829-4. Epub 2010 Mar 4. J Cancer Res Clin Oncol. 2010. PMID: 20204407

9

Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.

Ihnen M, Köhler N, Kersten JF, Milde-Langosch K, Beck K, Höller S, Müller V, Witzel I, Jänicke F, Kilic E. Ihnen M, et al. Among authors: witzel i. Dis Markers. 2010;28(2):71-8. doi: 10.3233/DMA-2010-0685. Dis Markers. 2010. PMID: 20364042 Free PMC article.

10

Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial.

Witzel I, Loibl S, von Minckwitz G, Mundhenke C, Huober J, Hanusch C, Henschen S, Hauschild M, Lantzsch T, Tesch H, Latos K, Just M, Hilfrich J, Barinoff J, Eulenburg CZ, Roller M, Untch M, Müller V. Witzel I, et al. Breast Cancer Res Treat. 2010 Sep;123(2):437-45. doi: 10.1007/s10549-010-1030-9. Epub 2010 Jul 10. Breast Cancer Res Treat. 2010. PMID: 20623180 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page